Chitosan-Functionalized Fluorescent Calcium Carbonate Nanoparticle Loaded with Methotrexate: Future Theranostics for Triple Negative Breast Cancer
ACS Biomaterials Science & Engineering · 2025
DOI: 10.1021/acsbiomaterials.4c02390 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2025. Verfasst von Rinki Verma und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, IIT (BHU), Varanasi 221005, India. Hauptthemen laut MEDLINE: Methotrexate, Triple Negative Breast Neoplasms, Chitosan, Nanoparticles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 62 Literaturangaben.
Abstract (Originalsprache)
Herein, fluorescent calcium carbonate nanoclusters encapsulated with methotrexate (Mtx) and surface functionalized with chitosan (25 nm) (@Calmat) have been developed for the imaging and treatment of triple-negative breast cancer (TNBC). These biocompatible, pH-sensitive nanoparticles demonstrate significant potential for targeted therapy and diagnostic applications. The efficacy of nanoparticles (NPs) was evaluated in MDA-MB-231 TNBC cell lines. The enhanced permeability and retention effect facilitated the accumulation of NPs, in tumor-bearing rats, as confirmed by in vivo fluorescence imaging. Treatment with @Calmat resulted in a marked reduction in pro-inflammatory cytokines, with levels of IL-6 (1225 ± 67 pg/mL), IL-1β (379 ± 69 pg/mL), and TNF-α (14.1 ± 2 pg/mL), in contrast to the diseased control group (IL-6: 2223 ± 99; IL-1β: 1632 ± 90; TNF-α: 40 ± 3 pg/mL). A similar trend was observed for liver and kidney function biomarkers. Mechanistic studies revealed that @Calmat treatment activates the Bax/Bcl-2 signaling pathway, leading to cell cycle arrest in the G1 phase and subsequent late-phase apoptosis. As a result, the tumor inhibition rate reached 88%, with 80% of treated rats surviving beyond 100 days. These findings highlight the strong potential of @Calmat as a dual-function theranostic agent for the management of TNBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering, IIT (BHU), Varanasi 221005, India.
- Department of Zoology, Institute of Science, Banaras Hindu University, Varanasi 221005, India.
- Nano 2 Micro Material Design Lab, Department of Chemical Engineering and Technology, IIT (BHU), Varanasi 221005, India.
ORCID-Profile: Manoj Kumar
Zitieren
APA
Verma, R., Zeyaullah, M., Singh, V., Saxena, P. S., Koch, B., & Kumar, M. (2025). Chitosan-Functionalized Fluorescent Calcium Carbonate Nanoparticle Loaded with Methotrexate: Future Theranostics for Triple Negative Breast Cancer. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.4c02390
Vancouver
Verma R, Zeyaullah M, Singh V, Saxena PS, Koch B, Kumar M. Chitosan-Functionalized Fluorescent Calcium Carbonate Nanoparticle Loaded with Methotrexate: Future Theranostics for Triple Negative Breast Cancer. ACS Biomaterials Science & Engineering. 2025. doi:10.1021/acsbiomaterials.4c02390
BibTeX
@article{Verma2025,
author = {Verma, Rinki and Zeyaullah, Md and Singh, Virendra and Saxena, Preeti Suman and Koch, Biplob and Kumar, Manoj},
title = {Chitosan-Functionalized Fluorescent Calcium Carbonate Nanoparticle Loaded with Methotrexate: Future Theranostics for Triple Negative Breast Cancer},
journal = {ACS Biomaterials Science & Engineering},
year = {2025},
doi = {10.1021/acsbiomaterials.4c02390}
}
EUVIMED